Form 4/A for ORIC Oric Pharmaceuticals, Inc.
Accepted 2023-02-17 00:00:00 ET · period of report 2022-12-15 · accession 0001209191-23-010616 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2023-02-17 | 2022-12-15 | ORIC | Multani Pratik S | Chief Medical Off | S - Sale | $3.07 | -2,227 | 7,285 | -23% | -$6,837 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-15 | S | D | 2,227 | $3.07 | 7,285 | D | — | — | (F1) This amendment is filed to correct the number of shares sold, and the price per share at which the shares were sold, to cover the tax withholding obligations in connection with the vesting of RSUs reported in the Form 4 filed December 16, 2022 and does not represent a discretionary sale by the Reporting Person. |